Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Montana Wildhack who wrote (7900)	10/27/2001 12:07:09 PM
From: shakedown	Read Replies (1) of 14101

Wolf, I'm not sure if this is what you are looking for: biospace.com 10-02-01 - Receives European Commitments For Approval Of PENNSAID. 07-05-01 - Announces Caribbean Distribution Agreement With A.S. Bryden & Sons (Barbados) Ltd. 03-01 - Launched in the UK. 01-30-01 - Commenced in the European Union Mutual Recognition Procedure. 01-08-01 - Announces U.K. Sales And Marketing Agreement With Provalis For PENNSAID(R). 11-27-00 - Receives final approval in the UK. 10-00 - NDS filed in Canada. 10-02-00 - Announces Positive Clinical Results For PENNSAID(R). 1999 - Approved in UK (Applied 1/97). 05-21-99 - Dimethaid Research And Johnson & Johnson's McNeil Consumer Healthcare Agree To Exclusive Negotiations For U.S. Distribution Of PENNSAID(R). 03-98 - FDA accepts NDA for filing. 12-95 - Completed phase III trials. Warren

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next